Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Ani Pharmaceuticals (ANIP) over the last 16 years, with Q3 2025 value amounting to 0.6.

  • Ani Pharmaceuticals' Asset Utilization Ratio rose 1948.21% to 0.6 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.6, marking a year-over-year increase of 1948.21%. This contributed to the annual value of 0.56 for FY2024, which is 399.7% down from last year.
  • As of Q3 2025, Ani Pharmaceuticals' Asset Utilization Ratio stood at 0.6, which was up 1948.21% from 0.57 recorded in Q2 2025.
  • Ani Pharmaceuticals' 5-year Asset Utilization Ratio high stood at 0.6 for Q3 2025, and its period low was 0.28 during Q4 2021.
  • In the last 5 years, Ani Pharmaceuticals' Asset Utilization Ratio had a median value of 0.48 in 2024 and averaged 0.46.
  • As far as peak fluctuations go, Ani Pharmaceuticals' Asset Utilization Ratio plummeted by 3834.73% in 2021, and later soared by 5772.73% in 2023.
  • Over the past 5 years, Ani Pharmaceuticals' Asset Utilization Ratio (Quarter) stood at 0.28 in 2021, then soared by 51.68% to 0.42 in 2022, then rose by 28.56% to 0.54 in 2023, then fell by 11.92% to 0.48 in 2024, then rose by 25.78% to 0.6 in 2025.
  • Its last three reported values are 0.6 in Q3 2025, 0.57 for Q2 2025, and 0.52 during Q1 2025.